Table 4.
Results of multiple regression analysis with symptom domains as dependent variables and cytokines/chemokines/growth factors as explanatory variables.
| Dependent variables | Explanatory variables | Coefficients of input variables | Model statistics | |||||
|---|---|---|---|---|---|---|---|---|
| β | T | p | R2 | F | df | p | ||
| #1. Pure depression | Model | 0.489 | 29.29 | 3/92 | < 0.001 | |||
| IL-16 | 0.593 | 6.87 | < 0.001 | |||||
| CCL3 | − 0.453 | − 0.38 | < 0.001 | |||||
| SCGF | 0.275 | 2.16 | 0.033 | |||||
| #2 Pure anxiety | Model | 0.454 | 25.55 | 3/92 | < 0.001 | |||
| IL-16 | 0.593 | 6.87 | < 0.001 | |||||
| CCL3 | − 0.453 | − 3.83 | < 0.001 | |||||
| IL-17 | 0.275 | 2.16 | 0.033 | |||||
| #3. Physiosomatic symptoms | Model | 0.590 | 25.88 | 5/90 | < 0.001 | |||
| IL-16 | 0.861 | 9.28 | < 0.001 | |||||
| CCL3 | − 0.398 | − 4.93 | < 0.001 | |||||
| sIL-1RA | − 0.266 | − 2.85 | 0.005 | |||||
| Sex | 0.266 | 3.58 | < 0.001 | |||||
| IL-8 | 0.252 | 3.09 | 0.003 | |||||
| #4. Pure FF | Model | 0.465 | 26.63 | 3/92 | < 0.001 | |||
| IL-16 | 0.736 | 5.68 | < 0.001 | |||||
| CIRS | − 0.468 | − 4.10 | < 0.001 | |||||
| TRAIL | 0.269 | 2.27 | 0.026 | |||||
| #5. Melancholia | Model | 0.532 | 34.92 | 3/92 | < 0.001 | |||
| IL-16 | 0.492 | 4.72 | < 0.001 | |||||
| SCGF | 0.306 | 3.02 | 0.003 | |||||
| CCL | − 0.197 | − 2.63 | 0.010 | |||||
| #6. GIS | Model | 0.494 | 17.55 | 5/90 | < 0.001 | |||
| IL-16 | 0.305 | 2.47 | 0.016 | |||||
| CCL3 | − 0.395 | − 4.59 | < 0.001 | |||||
| CCL1 | 0.310 | 3.71 | < 0.001 | |||||
| TRAIL | 0.271 | 2.35 | 0.021 | |||||
| IL-8 | 0.171 | 2.04 | 0.044 | |||||
| #7. Insomnia | Model | 0.541 | 36.17 | 3/92 | < 0.001 | |||
| IL-16 | 0.676 | 5.57 | < 0.001 | |||||
| sIL-1RA | − 0.276 | − 2.85 | 0.005 | |||||
| SCGF | 0.271 | 2.75 | 0.007 | |||||
| #8. Autonomic | Model | 0.057 | 5.65 | 1/94 | 0.019 | |||
| TRAIL | 0.238 | 2.38 | 0.019 | |||||
IL interleukin, SCGF stem cell growth factor, sIL-1RA soluble IL-1 receptor antagonist, sex males = 1, females = 0, CIRS compensatory immunoregulatory system, TRAIL tumor necrosis factor-related apoptosis-inducing ligand.